Lichee-like core-shell structured magnetic lutetium phosphate (FeO@LuPO) affinity microspheres were successfully synthesized and well characterized. Based on the properties of great specificity and rapid separation, magnetic LuPO microspheres were applied to selectively enrich phosphopeptides for MALDI-TOF MS analysis. The enrichment performance of the prepared microspheres was demonstrated by tryptic digests of standard protein (β-casein), complex samples (tryptic digest mixture of β-casein and bovine serum albumin at different molar ratios of 1 : 10 to 1 : 50), and real biological samples (fresh pure milk and human serum), respectively. The enrichment ability of magnetic LuPO microspheres for phosphopeptides was very satisfying and the captured phosphopeptides with a sharp enhancement in MS signals were reliably identified based on the appearance of metastable ion peaks with poor resolution of the corresponding dephosphorylated peptides in the mass spectra. Enrichment of phosphopeptides by the FeO@LuPO affinity microspheres provides a powerful approach for large scale phosphoproteome analysis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c5tb01378j | DOI Listing |
Cancers (Basel)
April 2024
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA 94143, USA.
This study aimed to develop a rapid, 1 mm isotropic resolution, whole-brain MRI technique for automatic lesion segmentation and multi-parametric mapping without using contrast by continuously applying balanced steady-state free precession with inversion pulses throughout incomplete inversion recovery in a single 6 min scan. Modified k-means clustering was performed for automatic brain tissue and lesion segmentation using distinct signal evolutions that contained mixed T1/T2/magnetization transfer properties. Multi-compartment modeling was used to derive quantitative multi-parametric maps for tissue characterization.
View Article and Find Full Text PDFNeurosurgery
September 2024
Department of Radiology, Medical College of Wisconsin, Milwaukee , Wisconsin , USA.
Background And Objectives: This study identified a clinically significant subset of patients with glioma with tumor outside of contrast enhancement present at autopsy and subsequently developed a method for detecting nonenhancing tumor using radio-pathomic mapping. We tested the hypothesis that autopsy-based radio-pathomic tumor probability maps would be able to noninvasively identify areas of infiltrative tumor beyond traditional imaging signatures.
Methods: A total of 159 tissue samples from 65 subjects were aligned to MRI acquired nearest to death for this retrospective study.
J Magn Reson Imaging
October 2024
Department of Radiology and Biomedical Imaging, UCSF, San Francisco, California, USA.
Background: Pathophysiological changes of Huntington's disease (HD) can precede symptom onset by decades. Robust imaging biomarkers are needed to monitor HD progression, especially before the clinical onset.
Purpose: To investigate iron dysregulation and microstructure alterations in subcortical regions as HD imaging biomarkers, and to associate such alterations with motor and cognitive impairments.
Stroke
January 2024
Neurovascular Surgery Program, Department of Neurological Surgery (S.H., S.K., R.G., J.L., A.S., R.J.A.-F., R.S., N.H., D.D., I.A.A.), University of Chicago Medicine and Biological Sciences, IL.
Background: Quantitative susceptibility mapping (QSM) and dynamic contrast-enhanced quantitative perfusion (DCEQP) magnetic resonance imaging sequences assessing iron deposition and vascular permeability were previously correlated with new hemorrhage in cerebral cavernous malformations. We assessed their prospective changes in a multisite trial-readiness project.
Methods: Patients with cavernous malformation and symptomatic hemorrhage (SH) in the prior year, without prior or planned lesion resection or irradiation were enrolled.
Magn Reson Med
March 2024
Cardiovascular Magnetic Resonance Unit, The Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!